Feb 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 22 mln 37 mln 26 mln 17 mln
(-40.6 pct) (+43.1 pct) (+20.7 pct) (+68.7 pct)
Operating loss 1.34 loss 999 mln loss 1.42 loss 514 mln
Recurring loss 1.30 loss 990 mln loss 1.40 loss 499 mln
Net
Net loss 1.26 loss 878 mln loss 1.37 loss 459 mln
EPS loss 155.48 yen loss 131.21 yen loss 160.49 yen loss 53.92 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T
((Tokyo Headline News Desk +813 6441 1812))